What is he best known for?
The fields of study he is best known for:
His primary areas of study are Hippo signaling pathway, Cell biology, Signal transduction, Kinase and Nuclear protein.
His Hippo signaling pathway study integrates concerns from other disciplines, such as Cancer, Cancer research and Bioinformatics.
His Bioinformatics research is multidisciplinary, incorporating perspectives in Germline mutation, Signaling network, Model organism and YAP1.
Kieran F. Harvey combines subjects such as NEDD4, Cadherin, Cell cycle and Cell growth with his study of Cell biology.
The Hippo signaling study combines topics in areas such as WWTR1 and MST1.
His study in MAP kinase kinase kinase is interdisciplinary in nature, drawing from both Drosophila melanogaster, Transcription factor, Apoptosis Inhibitor and Genetic screen.
His most cited work include:
- The Hippo pathway and human cancer (1022 citations)
- The Hippo pathway and human cancer (1022 citations)
- The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis (693 citations)
What are the main themes of his work throughout his whole career to date?
Hippo signaling pathway, Cell biology, Signal transduction, Drosophila melanogaster and Transcription factor are his primary areas of study.
His Hippo signaling pathway research is multidisciplinary, relying on both Cancer research and Nuclear protein.
His Cancer research study combines topics in areas such as Cancer and Oncogene.
His Cell biology research integrates issues from Cell growth, Cell fate determination, Regulator, Transcription and Genetic screen.
His Signal transduction study also includes
- Imaginal disc which is related to area like Anatomy,
- Molecular biology which is related to area like Gene.
Kieran F. Harvey has researched Hippo signaling in several fields, including Cell cycle and MST1.
He most often published in these fields:
- Hippo signaling pathway (129.01%)
- Cell biology (122.90%)
- Signal transduction (50.38%)
What were the highlights of his more recent work (between 2018-2021)?
- Hippo signaling pathway (129.01%)
- Cell biology (122.90%)
- Cancer research (41.98%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Hippo signaling pathway, Cell biology, Cancer research, Melanoma and Cutaneous melanoma.
His Hippo signaling pathway research is mostly focused on the topic Hippo signaling.
Kieran F. Harvey interconnects Cell culture and Gene knockdown in the investigation of issues within Hippo signaling.
His work deals with themes such as Histone acetyltransferase, Transcription factor, Gene expression and Histone acetyltransferase complex, which intersect with Cell biology.
In his research, Transcription, Genetics and Drosophila melanogaster is intimately related to Effector, which falls under the overarching field of Transcription factor.
His research in Cancer research intersects with topics in Mutation, Cell, Mesothelioma and Cancer.
Between 2018 and 2021, his most popular works were:
- Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma. (14 citations)
- Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma. (14 citations)
- The regulation of Yorkie, YAP and TAZ: new insights into the Hippo pathway. (11 citations)
In his most recent research, the most cited papers focused on:
Kieran F. Harvey focuses on Hippo signaling pathway, Cancer research, Cutaneous melanoma, Neuroblastoma RAS viral oncogene homolog and Melanoma.
He merges many fields, such as Hippo signaling pathway and Somatic hypermutation, in his writings.
His work often combines Somatic hypermutation and Oncogene studies.
His Cell research includes elements of Metastasis and Skin cancer.
In the field of Cell biology and Signal transduction Kieran F. Harvey studies Hedgehog signaling pathway.
Kieran F. Harvey combines topics linked to Cancer with his work on Mutation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
